Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2003
04/24/2003US20030077318 Activation lymphocytes; therapy for aids, cancer; immobilization on solid support
04/24/2003US20030077313 Anti-stress composition intended for incorporation mainly in nutritional vehicles
04/24/2003US20030077291 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
04/24/2003US20030077289 Administering an immune effector cell containing a cell penetrating peptide associated with an antigen for enhancing an immune response in an animal to a disease
04/24/2003US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells
04/24/2003US20030077279 Methods for treating vascular disease by inhibiting toll-like receptor-4
04/24/2003US20030077267 Purified forms of DNase
04/24/2003US20030077264 Storage additive solutions of invention can increase platelet storage life by at least 20%, preferably 40%
04/24/2003US20030077259 Induction of beta cell differentiation in human cells
04/24/2003US20030077258 Comprising one or more chondroitin sulfate proteoglycan (CSPG)-degrading enzymes that promote axonal penetration into damaged nerve tissue and nerve graft
04/24/2003US20030077257 Administering a dosage of alive larva of nematodes; immunogens treating cancer of the first and second stages, and AIDS-infections
04/24/2003US20030077256 Pancreas regeneration using embryonic pancreatic cells
04/24/2003US20030077255 Compositions of bacteria and alpha-lactalbumin and uses thereof
04/24/2003US20030077253 Implantable or insertable therapeutic agent delivery device
04/24/2003US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease
04/24/2003US20030077248 Treating cancer with a culture product from a non-naturally occurring antigen-presenting cell; polyclonal antibodies expression
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003US20030075187 Mixed chimerism and tolerance
04/24/2003DE20301069U1 Composition for treating type II diabetes by activating insulin naturally present in the body, comprises petroleum and spirit vinegar, preferably diluted with water
04/24/2003CA2775218A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
04/24/2003CA2466889A1 Use of the adenoviral e2 late promoter
04/24/2003CA2463996A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications
04/24/2003CA2463979A1 Method of producing human beta cell lines
04/24/2003CA2463914A1 Conversion of liver stem and progenitor cells to pancreatic functional cells
04/24/2003CA2463850A1 Remodeling of tissues and organs
04/24/2003CA2463711A1 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
04/24/2003CA2463020A1 Use of gp130 activators in diabetic neuropathy
04/24/2003CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003CA2459572A1 Composition comprising a lactobacillus pentosus strain and uses thereof
04/23/2003EP1304116A1 New class of bioactive glycoprotein
04/23/2003EP1304114A1 Adsorbent for endocrine disruptors and foods and drinks containing the same
04/23/2003EP1304113A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304112A1 Isolated stromal cells and methods of using the same
04/23/2003EP1303620A2 Regulation of human desc1-like serine protease
04/23/2003EP1303613A2 Rescue of canine distemper virus from cdna
04/23/2003EP1303588A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
04/23/2003EP1303310A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
04/23/2003EP1303302A2 Use of strains of the parapox ovis virus against organ fibrosis
04/23/2003EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
04/23/2003EP1303285A2 Methods and formulations with probiotic microorganisms and medicaments
04/23/2003EP1303284A1 Compositions and methods for the treatment of skin damage
04/23/2003EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1028738B1 Use of cytokines and mitogens to inhibit pathological immune responses
04/23/2003EP0863762A4 Methods of production and use of liquid formulations of plasma proteins
04/23/2003EP0840618B1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
04/23/2003EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells
04/23/2003CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls
04/23/2003CN1413125A Sensitive substance encapsulation
04/23/2003CN1413120A Method of inactivating pathogens
04/23/2003CN1413116A Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract
04/23/2003CN1413115A Virus-free plasma protein compositions treated with porous membrane and process for producing the same
04/23/2003CN1412556A Biological assay method of rogal jelly and freeze-dried powder activity
04/23/2003CN1412297A Fermentation method of engineering bacterium for producing anti-cacer medicine
04/23/2003CN1412295A Oncolytic microorganism expressing heat shock protein and its application
04/23/2003CN1411868A Bone-joining elixir and its preparation method
04/23/2003CN1411860A Tianqi sugar-reducing capsule
04/23/2003CN1411848A Chinese medicine liquor for clearing and activating channels and collaterals
04/23/2003CN1411842A Chinese medicine capsule for curing facial acne
04/23/2003CN1411841A Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method
04/23/2003CN1411840A Chinese medicine for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method
04/23/2003CN1411827A Capsule for curing acne
04/23/2003CN1411825A Medicine for curing burn and scald and its production method
04/23/2003CN1411822A 疮疡愈合散 San sore healing
04/23/2003CN1411821A Medicine for curing angiocardiopathy and its preparation method
04/23/2003CN1411820A Low agglutinin universal refrigerated plasma
04/23/2003CN1411819A Production method of human whole blood serum
04/23/2003CN1411818A Anticoagulant for prolonging external hemolymph cell life and its application method
04/23/2003CN1411817A Medicine for external application for curing psoriasis
04/23/2003CN1411805A Biological medicine film and its preparation method
04/23/2003CN1106202C Anti-aids immunomodulator complex
04/23/2003CN1106200C Togluo Ruanjiangao plaster and its preparing method
04/23/2003CN1106199C Pure Chinese medicine anti-tumour medicine and its preparing process
04/23/2003CN1106198C Production process of biological active woodfrog fat capsule
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6551996 Super-active porcine growth hormone releasing hormone analog
04/22/2003US6551990 Methods of inhibiting ectopic calcification
04/22/2003US6551830 Rh blood group antigen compositions and methods of use
04/22/2003US6551631 Isolated from gel; bactericides for drug resistant bacteria
04/22/2003US6551623 Immunomodulating compositions from bile
04/22/2003US6551607 Method for sequestration of skin irritants with substrate compositions
04/22/2003US6551595 Smallpox inhibitor of complement enzymes (SPICE) protein and methods of inhibiting complement activation
04/22/2003US6551589 Obtaining cell derived antigens (CDAs) from the body as well as mononuclear cells to be placed in the body; reacting mononuclear cells in vitro with the CDAs and recovering those that do not bind the antigens; prevent graft vs host disease
04/22/2003US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector.
04/22/2003CA2152941C Cytopathic viruses for therapy and prophylaxis of neoplasia
04/22/2003CA2098295C G protein-coupled glutamate receptors
04/17/2003WO2003031643A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen
04/17/2003WO2003031640A2 Preadipocyte cell strains and uses therefore
04/17/2003WO2003031602A1 The oncolytic microorganisms expressing hsp and uses thereof
04/17/2003WO2003031588A2 Hepatitis c virus vaccine
04/17/2003WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
04/17/2003WO2003030938A1 Immunotherapeutics for cancer
04/17/2003WO2003030918A1 Pharmaceutical product or food supplement and intermediate product to be used therewith
04/17/2003WO2003030917A1 Bactericide for mrsa
04/17/2003WO2003030873A1 Therapeutic biological product and method for formation of new vascularised bone
04/17/2003WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003WO2003030822A2 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
04/17/2003WO2003030820A2 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae
1 ... 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 ... 1259